These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 8852002

  • 1. [Experience with pupil tropicamide test in Alzheimer's disease].
    Robles A, Touriño R, Sesar A, Suárez P, Noya M.
    Rev Neurol; 1996 Jan; 24(125):65-8. PubMed ID: 8852002
    [Abstract] [Full Text] [Related]

  • 2. The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia.
    Robles A, Touriño R, Gude F, Noya M.
    Funct Neurol; 1999 Jan; 14(4):203-7. PubMed ID: 10713893
    [Abstract] [Full Text] [Related]

  • 3. Pupil dilation response to tropicamide: a biological test for Alzheimer's disease?
    Kurz A, Marquard R, Fremke S, Leipert KP.
    Pharmacopsychiatry; 1997 Jan; 30(1):12-5. PubMed ID: 9065964
    [Abstract] [Full Text] [Related]

  • 4. Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia.
    Higuchi S, Matsushita S, Hasegawa Y, Muramatsu T, Arai H.
    Exp Neurol; 1997 Mar; 144(1):199-201. PubMed ID: 9126171
    [Abstract] [Full Text] [Related]

  • 5. A combination solution for routine pupillary dilation.
    Krumholz DM, Portello JK, Rosenfield M, Rosenbaum JD.
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [Abstract] [Full Text] [Related]

  • 6. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation.
    Ratanapakorn T, Yospaiboon Y, Chaisrisawadsuk N.
    J Med Assoc Thai; 2006 Nov; 89(11):1934-9. PubMed ID: 17205877
    [Abstract] [Full Text] [Related]

  • 7. ApoE allelic variability influences pupil response to cholinergic challenge and cognitive impairment.
    Scinto LF.
    Genes Brain Behav; 2007 Apr; 6(3):209-15. PubMed ID: 16764677
    [Abstract] [Full Text] [Related]

  • 8. Probing peripheral and central cholinergic system responses.
    Naranjo CA, Fourie J, Herrmann N, Lanctôt KL, Birt C, Yau KK.
    J Psychiatry Neurosci; 2000 Sep; 25(4):325-36. PubMed ID: 11022397
    [Abstract] [Full Text] [Related]

  • 9. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.
    Encephale; 2003 Sep; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [Abstract] [Full Text] [Related]

  • 10. Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's dementia.
    Kálmán J, Kanka A, Maglóczky E, Szóke A, Járdánházy T, Janka Z.
    Biol Psychiatry; 1997 Apr 15; 41(8):909-11. PubMed ID: 9099419
    [No Abstract] [Full Text] [Related]

  • 11. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.
    Eyeson-Annan ML, Hirst LW, Battistutta D, Green A.
    Ophthalmology; 1998 Apr 15; 105(4):726-32. PubMed ID: 9544648
    [Abstract] [Full Text] [Related]

  • 12. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
    Stadtbäumer K, Frommlet F, Nell B.
    Vet Ophthalmol; 2006 Apr 15; 9(4):233-7. PubMed ID: 16771758
    [Abstract] [Full Text] [Related]

  • 13. [The pupillary response test as a method to differentiate various types of dementia].
    Grünberger J, Prause W, Frottier P, Stöhr H, Saletu B, Haushofer M, Rainer M.
    Neuropsychiatr; 2009 Apr 15; 23(1):52-7. PubMed ID: 19272292
    [Abstract] [Full Text] [Related]

  • 14. Pupil dilatation assay by tropicamide is modulated by apolipoprotein E epsilon 4 allele dosage in Alzheimer's disease.
    Arai H, Terajima M, Nakagawa T, Higuchi S, Mochizuki H, Sasaki H.
    Neuroreport; 1996 Mar 22; 7(4):918-20. PubMed ID: 8724673
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis.
    Ghose S, Garodia VK, Sachdev MS, Kumar H, Biswas NR, Pandey RM.
    Invest Ophthalmol Vis Sci; 2001 Jun 22; 42(7):1581-5. PubMed ID: 11381064
    [Abstract] [Full Text] [Related]

  • 16. Re-evaluation of tropicamide in the pupillary response test for Alzheimer's disease.
    Iijima A, Haida M, Ishikawa N, Ueno A, Minamitani H, Shinohara Y.
    Neurobiol Aging; 2003 Oct 22; 24(6):789-96. PubMed ID: 12927761
    [Abstract] [Full Text] [Related]

  • 17. Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders.
    Gómez-Tortosa E, del Barrio A, Jiménez-Alfaro I.
    Acta Neurol Scand; 1996 Aug 22; 94(2):104-9. PubMed ID: 8891054
    [Abstract] [Full Text] [Related]

  • 18. Effects of systemic administration of 0.5% tropicamide on intraocular pressure, pupillary diameter, blood pressure, and heart rate in normal cats.
    Schmidt KS, Hacker DV, Kass PH, Barkhoodarian AL.
    Vet Ophthalmol; 2006 Aug 22; 9(2):137-9. PubMed ID: 16497239
    [Abstract] [Full Text] [Related]

  • 19. Pupil dilation to tropicamide is not specific for Alzheimer disease.
    Growdon JH, Graefe K, Tennis M, Hayden D, Schoenfeld D, Wray SH.
    Arch Neurol; 1997 Jul 22; 54(7):841-4. PubMed ID: 9236572
    [Abstract] [Full Text] [Related]

  • 20. [Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome].
    Kono K, Miyao M, Ishihara S, Takagi A, Ikari H, Suzuki Y, Iguchi A.
    Nihon Ronen Igakkai Zasshi; 1996 Nov 22; 33(11):829-34. PubMed ID: 8997102
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.